Advertisement Novasep - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


Quick Contact Novasep



Novasep is a leading worldwide provider of integrated manufacturing solutions for the life science industries. We develop, market and operate innovative technologies from lab to industrial scale to produce biomolecules and synthetic molecules for the pharmaceutical, biopharmaceutical, agrochemical, fine chemical and industrial biotechnology markets.

Biomolecule and synthetic molecule production

In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model, which includes:

  • Process development services
  • Custom synthesis and biomanufacturing (outsourcing solutions)
  • Purification processes, equipment and consumables (insourcing solutions)
  • Fine chemicals and generic active pharmaceutical ingredients

Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.

We operate through two complementary business divisions, Novasep Process and Novasep Synthesis.

Synthesis and purification of active pharmaceutical ingredients

Our offering for synthetic molecules consists of: multi-step synthesis and purification of active pharmaceutical ingredients (APIs) and advanced intermediates, agrochemicals and fine chemicals; purification processes, equipment and products for APIs, synthetic peptides and fine chemicals; as well as special reagents, building blocks and generic APIs.

Our offering for biomolecules consists of: upstream and downstream processing, formulation and fill and finish of biopharmaceuticals; production of functional ingredients; purification processes, systems and consumables for biopharmaceutical, food, functional and bio-industrial applications.

Our customers benefit from our process intelligence:

  • coming from the cross-fertilisation of our experience acquired within diverse applications,
  • backed by our expertise in both using and developing our own technologies.

The company has six FDA inspected manufacturing plants in France, Germany and the Bahamas; two biopharmaceutical production sites in Belgium; R&D and equipment manufacturing facilities in the USA, China and France; and an office in Japan. It employs approximately 1,200 people and had annual revenues of EUR300 million in 2010. More than 2,000 systems designed and produced by Novasep are currently purifying active molecules throughout the world.

Contact details:

Site Eiffel
81 Boulevard de la Moselle
BP 50 – 54340 Pompey
Tel: +33 3 83 49 71 00
Fax: +33 3 83 49 71 02

Quick Contact Novasep

Top Products from Novasep

Quick Contact Novasep
Quick Contact Novasep
Quick Contact Novasep

Quick Contact Novasep
Quick Contact Novasep
Quick Contact Novasep

Contact Novasep

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact Novasep